Johannes Thomsen
Novo Nordisk
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Johannes Thomsen.
Scandinavian Journal of Clinical & Laboratory Investigation | 1975
Ebba Nexo; Henrik Olesen; Jytte Molin Christensen; Johannes Thomsen; K. Kristiansen
A cobalamin-binding protein has been purified by affinity chromatography from plasma of a patient with hepatoma and a 10,000-fold increase in the concentration of the plasma cobalamin-binding capacity. The protein behaved as normal transcobalamin I in gel filtration, agar gel electrophoresis, immunoelectrophoresis, precipitation by ammonium sulphate, and cobalamin-binding studies. The protein contained 38 per cent carbohydrate, and the relative molecular mass based on amino acid and carbohydrate analyses was 69,000. The molar absorption coefficient of cyanocobalamin bound to the protein was determined to be 36,000 at 362 nm. On amino acid sequencing, one amino terminal was found, and the first 13 residues were determined as Glu-Ile-Ser/Cys-Glu-Val-Ser/Cys-Glu-Glu-Asx-Tyr-Ile-Arg-Leu/Ile.
Scandinavian Journal of Clinical & Laboratory Investigation | 1978
Ebba Nexo; Henrik Olesen; Marianne Rye Hansen; Ditlef Bucher; Johannes Thomsen
Human intrinsic factor purified by labile ligand affinity chromatography was cleaved with cyanogen bromide and fractionated by gel filtration. Four of the fragments were purified and sequenced to a total of eighty-four amino acid residues. Including the N-terminal amino acids this amounts to one third of the total amino acid sequence of human intrinsic factor. One of the fragments contained a tyrosine labelled only on iodination of intrinsic factor devoid of cobalamin.
Scandinavian Journal of Clinical & Laboratory Investigation | 1976
Henrik Olesen; Ebba Nexo; P. Lous; Johannes Thomsen; Ditlef Bucher
Olesen, H., Nexo, E., Lous, P., Thomsen, J. & Bucher, D. Amino Terminal Sequence of Human Intrinsic Factor. Scand. J. clin. Lab. Invest. 36, 527–529, 1976.The N-terminal sequence of human intrinsic factor is hereby reported as: 1 5 10 Ser-Thr-Gln-Thr-Gln-Ser-Ser-Cys-Ser-Val-Pro-Ser-Ala-Gln-15 20 25 Glu-Pro-Leu-Val-Asn-Gly-Ile-Gln- -Leu-Met-Gul-Thr-It is concluded that the cysteine at position 8 is involved in a disulfide bridge in the native protein.
Archive | 1986
Thorkild Christensen; Jørli W. Hansen; John Pedersen; Henrik Dalbøge; Søren Carlsen; Ejner Bech Jensen; Karin Damm Jørgensen; Bo Dinesen; Povl Nilsson; Hans Holmegaard Sørensen; Johannes Thomsen; Anne-Marie Kappelgaard
The major component of human growth hormone (hGH) is a protein with 191 amino acid residues, and a molecular weight of approximately 22,000 D (22K-hGH). A minor component which constitutes about 5% of the more abundant form has a molecular weight of approximately 20,000 D. The minor form is derived from the major by deletion of 15 amino acid residues (32–46 of the 22K-isomer). Both molecules are single stranded, and two disulfide bridges stabilizes the structure. The N-terminus as well as the C-terminus is phenylalanine (Chawla et al., 1983).
FEBS Journal | 1991
Hans Flodgaard; Erik Østergaard; Stephen Bayne; Allan Svendsen; Johannes Thomsen; Michael Engels; Axel Wollmer
FEBS Journal | 1976
Johannes Thomsen; Ditlef Bucher; Kay Brunfeldt; Ebba Nexø; Henrik Olesen
Protein Engineering | 1992
Kim Ry Hejnaes; Stephen Bayne; Leif Nørskov; Hans Holmegaard; Hans Holmegaard Sørensen; Johannes Thomsen; Lauge Schäffer; Axel Wollmer; Lars Skriver
FEBS Journal | 1995
Marianne Kjalke; Anders Heding; Gert H. Talbo; Egon Persson; Johannes Thomsen; Mirella Ezban
Journal of Mass Spectrometry | 1990
Hans Holmegaard Sørensen; Johannes Thomsen; Stephen Bayne; Peter Højrup; Peter Roepstorff
Archive | 1989
Hans Flodgaard; Erik Østergaard; Johannes Thomsen; Stephen Bayne